Related references
Note: Only part of the references are listed.Engineered cardiac tissues: a novel in vitro model to investigate the pathophysiology of mouse diabetic cardiomyopathy
Xiang Wang et al.
ACTA PHARMACOLOGICA SINICA (2021)
The role of ferroptosis in ionizing radiation-induced cell death and tumor suppression
Guang Lei et al.
CELL RESEARCH (2020)
Rifampicin activates AMPK and alleviates oxidative stress in the liver as mediated with Nrf2 signaling
Eun Hye Lee et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2020)
Protective effects of sulforaphane on type 2 diabetes-induced cardiomyopathy via AMPK-mediated activation of lipid metabolic pathways and NRF2 function
Yike Sun et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2020)
Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence
Yi Tan et al.
NATURE REVIEWS CARDIOLOGY (2020)
Loss of Cardiac Ferritin H Facilitates Cardiomyopathy via Slc7a11-Mediated Ferroptosis
Xuexian Fang et al.
CIRCULATION RESEARCH (2020)
Distinct Types of Cell Death and the Implication in Diabetic Cardiomyopathy
Yun Chen et al.
FRONTIERS IN PHARMACOLOGY (2020)
MD2 activation by direct AGE interaction drives inflammatory diabetic cardiomyopathy
Yi Wang et al.
NATURE COMMUNICATIONS (2020)
Nrf2 and Ferroptosis: A New Research Direction for Neurodegenerative Diseases
Xiaohua Song et al.
FRONTIERS IN NEUROSCIENCE (2020)
The Implication of Oxidative Stress and AMPK-Nrf2 Antioxidative Signaling in Pneumonia Pathogenesis
Weitong Xu et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Ferroptosis as a target for protection against cardiomyopathy
Xuexian Fang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Understanding the mechanisms of reversal of type 2 diabetes
Roy Taylor et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
Involvement of cigarette smoke-induced epithelial cell ferroptosis in COPD pathogenesis
Masahiro Yoshida et al.
NATURE COMMUNICATIONS (2019)
Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition
Pouya Saeedi et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2019)
Pinolenic acid ameliorates oleic acid-induced lipogenesis and oxidative stress via AMPK/SIRT1 signaling pathway in HepG2 cells
Jing Zhang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2019)
被撤回的出版物: Receptor for advanced glycation end products reveals a mechanism regulating thyroid hormone secretion through the SIRT1/Nrf2 pathway (Retracted article. See vol. 122, 2021)
Xiao-Jun Chen et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis
Matthew Dodson et al.
REDOX BIOLOGY (2019)
Reactive oxygen species signalling in the diabetic heart: emerging prospect for therapeutic targeting
Adam J. Wilson et al.
HEART (2018)
Increased levels of advanced glycation end products positively correlate with iron overload and oxidative stress markers in patients with β-thalassemia major
Maryam Sadat Mirlohi et al.
ANNALS OF HEMATOLOGY (2018)
Neonatal Murine Engineered Cardiac Tissue Toxicology Model: Impact of Metallothionein Overexpression on Cadmium-Induced Injury
Haitao Yu et al.
TOXICOLOGICAL SCIENCES (2018)
Sulforaphane prevents angiotensin II-induced cardiomyopathy by activation of Nrf2 via stimulating the Akt/GSK-3ss/Fyn pathway
Ying Xin et al.
REDOX BIOLOGY (2018)
Transcriptional Regulation by Nrf2
Claudia Tonelli et al.
ANTIOXIDANTS & REDOX SIGNALING (2018)
Metallothionein Is Downstream of Nrf2 and Partially Mediates Sulforaphane Prevention of Diabetic Cardiomyopathy
Junlian Gu et al.
DIABETES (2017)
DJC Suppresses Advanced Glycation End Products-Induced JAK-STAT Signaling and ROS in Mesangial Cells
Min Sun et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2017)
Activation of AMPK is neuroprotective in the oxidative stress by advanced glycosylation end products in human neural stem cells
Chien-Hung Lin et al.
EXPERIMENTAL CELL RESEARCH (2017)
Inhibition of AGEs/RAGE/Rho/ROCK.pathway suppresses non-specific neuroinflammation by regulating BV2 microglial M1/M2 polarization through the NF-κB pathway
Jingkao Chen et al.
JOURNAL OF NEUROIMMUNOLOGY (2017)
NRF2 Is a Major Target of ARF in p53-Independent Tumor Suppression
Delin Chen et al.
MOLECULAR CELL (2017)
Advanced glycation end products influence oral cancer cell survival via Bcl-xl and Nrf-2 regulation in vitro
Shun-Yao Ko et al.
ONCOLOGY LETTERS (2017)
Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease
Brent R. Stockwell et al.
CELL (2017)
Advanced glycation end products in children with type 1 diabetes and early reduced diastolic heart function
Leif Brunvand et al.
BMC CARDIOVASCULAR DISORDERS (2017)
Deferiprone attenuates inflammation and myocardial fibrosis in diabetic cardiomyopathy rats
Chunbo Zou et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells
Xiaofang Sun et al.
HEPATOLOGY (2016)
Mangiferin suppressed advanced glycation end products (AGEs) through NF-κB deactivation and displayed anti-inflammatory effects in streptozotocin and high fat diet-diabetic cardiomyopathy rats
Jun Hou et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2016)
MST1 coordinately regulates autophagy and apoptosis in diabetic cardiomyopathy in mice
Mingming Zhang et al.
DIABETOLOGIA (2016)
The Keap1-Nrf2-ARE Pathway As a Potential Preventive and Therapeutic Target: An Update
Meng-Chen Lu et al.
MEDICINAL RESEARCH REVIEWS (2016)
Sulforaphane reduces advanced glycation end products (AGEs)-induced inflammation in endothelial cells and rat aorta
T. Matsui et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2016)
The neuroprotective role of metformin in advanced glycation end product treated human neural stem cells is AMPK-dependent
Ming-Min Chung et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2015)
Suppression of antioxidant Nrf-2 and downstream pathway in H9c2 cells by advanced glycation end products (AGEs) via ERR phosphorylation
Shun-Yao Ko et al.
BIOCHIMIE (2015)
AMPK Protects Leukemia-Initiating Cells in Myeloid Leukemias from Metabolic Stress in the Bone Marrow
Yusuke Saito et al.
CELL STEM CELL (2015)
Activated AMPK boosts the Nrf2/HO-1 signaling axis-A role for the unfolded protein response
Kristin Zimmermann et al.
FREE RADICAL BIOLOGY AND MEDICINE (2015)
SIRT1 suppresses cardiomyocyte apoptosis in diabetic cardiomyopathy: An insight into endoplasmic reticulum stress response mechanism
Rong Guo et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2015)
Obesity in a model of gpx4 haploinsufficiency uncovers a causal role for lipid-derived aldehydes in human metabolic disease and cardiomyopathy
Lalage A. Katunga et al.
MOLECULAR METABOLISM (2015)
Regulation of Nrf2-an update
Suryakant K. Niture et al.
FREE RADICAL BIOLOGY AND MEDICINE (2014)
Advanced glycation end products: role in pathology of diabetic cardiomyopathy
Vijaya Lakshmi Bodiga et al.
HEART FAILURE REVIEWS (2014)
Sulforaphane attenuates obesity by inhibiting adipogenesis and activating the AMPK pathway in obese mice
Kyeong-Mi Choi et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2014)
The AMPK Inhibitor Compound C Is a Potent AMPK-Independent Antiglioma Agent
Xiaona Liu et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Sulforaphane inhibits advanced glycation end product-induced pericyte damage by reducing expression of receptor for advanced glycation end products
Sayaka Maeda et al.
NUTRITION RESEARCH (2014)
Essential role of PH domain and leucine-rich repeat protein phosphatase 2 in Nrf2 suppression via modulation of Akt/GSK3β/Fyn kinase axis during oxidative hepatocellular toxicity
F. Rizvi et al.
CELL DEATH & DISEASE (2014)
Protein kinase RNA- like endoplasmic reticulum kinase (PERK) signaling pathway plays a major role in reactive oxygen species (ROS)- mediated endoplasmic reticulum stress- induced apoptosis in diabetic cardiomyopathy
Zhong-Wei Liu et al.
CARDIOVASCULAR DIABETOLOGY (2013)
Sirt1 resists advanced glycation end products-induced expressions of fibronectin and TGF-β1 by activating the Nrf2/ARE pathway in glomerular mesangial cells
Kaipeng Huang et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy
Xavier Palomer et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Red Meat, Dietary Heme Iron, and Risk of Type 2 Diabetes: The Involvement of Advanced Lipoxidation Endproducts
Desley L. White et al.
ADVANCES IN NUTRITION (2013)
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Scott J. Dixon et al.
CELL (2012)
Diabetic Downregulation of Nrf2 Activity via ERK Contributes to Oxidative Stress-Induced Insulin Resistance in Cardiac Cells In Vitro and In Vivo
Yi Tan et al.
DIABETES (2011)
AMPK-mediated GSK3β inhibition by isoliquiritigenin contributes to protecting mitochondria against iron-catalyzed oxidative stress
Song Hwa Choi et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Diabetic cardiomyopathy, causes and effects
Sihem Boudina et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2010)
AMP-Activated Protein Kinase Deficiency Enhances Myocardial Ischemia/Reperfusion Injury but Has Minimal Effect on the Antioxidant/Antinitrative Protection of Adiponectin
Yajing Wang et al.
CIRCULATION (2009)
Role of Iron Deficiency and Overload in the Pathogenesis of Diabetes and Diabetic Complications
Qiuju Liu et al.
CURRENT MEDICINAL CHEMISTRY (2009)
The role of zinc, copper and iron in the pathogenesis of diabetes and diabetic complications: Therapeutic effects by chelators
Yang Zheng et al.
HEMOGLOBIN (2008)
Metallothionein suppresses angiotensin II-Induced nicotinamide adenine dinucleotide phosphate oxidase activation, nitrosative stress, apoptosis, and pathological remodeling in the diabetic heart
Guihua Zhou et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
The role of iron in diabetes and its complications
Sundararaman Swaminathan et al.
DIABETES CARE (2007)
Advanced glycation end products and antioxidant status in type 2 diabetic patients with and without peripheral artery disease
Annunziata Lapolla et al.
DIABETES CARE (2007)
Attenuation by metallothionein of early cardiac cell death via suppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy
Lu Cai et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Glycogen synthase kinase-3β inhibits the xenobiotic and antioxidant cell response by direct phosphorylation and nuclear exclusion of the transcription factor Nrf2
Maria Salazar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
C16, a novel advanced glycation endproduct breaker, restores cardiovascular dysfunction in experimental diabetic rats
G Cheng et al.
ACTA PHARMACOLOGICA SINICA (2005)
Effects of sham air and cigarette smoke on A549 lung cells: implications for iron-mediated oxidative damage
JJ Mayo et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2004)
Hyperglycemia-induced apoptosis in mouse myocardium -: Mitochondrial cytochrome c-mediated caspase-3 activation pathway
L Cai et al.
DIABETES (2002)
Share Paper
